首页> 美国卫生研究院文献>Medical Physics >Experimental validation of deterministic Acuros XB algorithm for IMRT and VMAT dose calculations with the Radiological Physics Center’s head and neck phantom
【2h】

Experimental validation of deterministic Acuros XB algorithm for IMRT and VMAT dose calculations with the Radiological Physics Center’s head and neck phantom

机译:使用放射物理中心的头颈部幻像对IMRT和VMAT剂量计算进行确定性Acuros XB算法的实验验证

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Purpose: The purpose of this study was to verify the dosimetric performance of Acuros XB (AXB), a grid-based Boltzmann solver, in intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT).>Methods: The Radiological Physics Center (RPC) head and neck (H&N) phantom was used for all calculations and measurements in this study. Clinically equivalent IMRT and VMAT plans were created on the RPC H&N phantom in the Eclipse treatment planning system (version 10.0) by using RPC dose prescription specifications. The dose distributions were calculated with two different algorithms, AXB 11.0.03 and anisotropic analytical algorithm (AAA) 10.0.24. Two dose report modes of AXB were recorded: dose-to-medium in medium (Dm,m) and dose-to-water in medium (Dw,m). Each treatment plan was delivered to the RPC phantom three times for reproducibility by using a Varian Clinac iX linear accelerator. Absolute point dose and planar dose were measured with thermoluminescent dosimeters (TLDs) and GafChromic® EBT2 film, respectively. Profile comparison and 2D gamma analysis were used to quantify the agreement between the film measurements and the calculated dose distributions from both AXB and AAA. The computation times for AAA and AXB were also evaluated.>Results: Good agreement was observed between measured doses and those calculated with AAA or AXB. Both AAA and AXB calculated doses within 5% of TLD measurements in both the IMRT and VMAT plans. Results of AXB_Dm,m (0.1% to 3.6%) were slightly better than AAA (0.2% to 4.6%) or AXB_Dw,m (0.3% to 5.1%). The gamma analysis for both AAA and AXB met the RPC 7%/4 mm criteria (over 90% passed), whereas AXB_Dm,m met 5%/3 mm criteria in most cases. AAA was 2 to 3 times faster than AXB for IMRT, whereas AXB was 4–6 times faster than AAA for VMAT.>Conclusions: AXB was found to be satisfactorily accurate when compared to measurements in the RPC H&N phantom. Compared with AAA, AXB results were equal to or better than those obtained with film measurements for IMRT and VMAT plans. The AXB_Dm,m reporting mode was found to be closer to TLD and film measurements than was the AXB_Dw,m mode. AXB calculation time was found to be significantly shorter (× 4) than AAA for VMAT.
机译:>目的:本研究的目的是验证基于网格的Boltzmann求解器Acuros XB(AXB)在强度调制放射治疗(IMRT)和体积调制电弧治疗中的剂量学性能( VMAT)。>方法:在本研究中,将放射物理中心(RPC)头颈部(H&N)体模用于所有计算和测量。通过使用RPC剂量处方规范,在Eclipse治疗计划系统(版本10.0)中的RPC H&N幻像上创建了临床等效的IMRT和VMAT计划。使用两种不同的算法AXB 11.0.03和各向异性分析算法(AAA)10.0.24计算剂量分布。记录了AXB的两种剂量报告模式:介质中剂量对介质(Dm,m)和介质中剂量对水(Dw,m)。通过使用Varian Clinac iX线性加速器,每个处理计划均被发送到RPC幻像三次以提高可重复性。绝对点剂量和平面剂量分别通过热发光剂量计(TLD)和GafChromic®EBT2膜进行测量。使用轮廓比较和2D伽马分析来量化胶片测量值与AXB和AAA计算的剂量分布之间的一致性。还评估了AAA和AXB的计算时间。>结果:观察到的剂量与使用AAA或AXB计算的剂量之间观察到良好的一致性。在IMRT和VMAT计划中,AAA和AXB都计算了TLD测量值的5%以内的剂量。 AXB_Dm,m(0.1%至3.6%)的结果略好于AAA(0.2%至4.6%)或AXB_Dw,m(0.3%至5.1%)。 AAA和AXB的伽马分析均满足RPC 7%/ 4 mm标准(通过90%以上),而AXB_Dm,m在大多数情况下均满足5%/ 3 mm标准。 IMRT的AAA速度比AXB快2至3倍,而VMAT的AAA速度快于AAA 4-6倍。>结论:与RPC H&N幻象中的测量结果相比,AXB被认为令人满意。与AAA相比,AXB结果等于或优于IMRT和VMAT计划的胶片测量结果。发现AXB_Dm,m报告模式比AXB_Dw,m模式更接近TLD和胶片测量。对于VMAT,发现AXB计算时间比AAA明显短(×shorter4)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号